Definium Therapeutics, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2025
Total Assets: $440.1M
Liabilities Breakdown FY2025
Total Liabilities: $107.8M
Asset Breakdown
Total Assets: $440.1M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $257.8M | 58.6% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $0 | 0.0% |
| Goodwill | $19.9M | 4.5% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $162.3M | 36.9% |
Liabilities Breakdown
Total Liabilities: $107.8M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $5.3M | 5.0% |
| Long-Term Debt | $40.6M | 37.7% |
| Other Liabilities | $61.8M | 57.4% |